Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018

BACKGROUND: A novel meningococcal serogroup A conjugate vaccine (MACV [MenAfriVac]) was developed as part of efforts to prevent frequent meningitis outbreaks in the African meningitis belt. The MACV was first used widely and with great success, beginning in December 2010, during initial deployment i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Infect Dis
Egile Nagusiak: Bwaka, Ado, Bita, André, Lingani, Clément, Fernandez, Katya, Durupt, Antoine, Mwenda, Jason M, Mihigo, Richard, Djingarey, Mamoudou H, Ronveaux, Olivier, Preziosi, Marie-Pierre
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Supplement Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822965/
https://ncbi.nlm.nih.gov/pubmed/31671448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz336
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak